Q: On Oct 1, Beam Therapeutics announced an equity offering priced at $23.50/share; over the following days, the share price declined to as low as $22.24, i.e., below the offering price, though not as low as would reflect the dilutive effect of the new shares.
Yet today shares traded as high as $34.38; what, if anything, can we infer from this disconnect? Who would pay so much when new shares can be had at 2/3 the price?
Q: Recently heard that E-commerce is entering car selling and buying sector. Carvana Co. and Vroom Inc. are two US companies selling and buying cars online. I wonder if they are a rival to each other. If yes, who is the sector leader? What do you think of this space? investable?
Thanks,
Lin
Q: Gentelmen:
Is monthly income received from LIFE etf interest income or capital gains from covered call writing & dividend from constituent securities?
Thank you
Q: A few weeks ago you said that close to 40 % of the dividend paid by ZWU in2019 was actually return of equity. Would you know if this would be more or less true about most years?
Also, you don't seem to have a very high opinion of ZWU. Why then do you include it in your Model ETF Portfolio?
Thank you
jerry
Q: Government uses previous year total income to determine if one is qualified for GIS (guaranteed incoming supplement). I would like to know if the GIS received from previous year is also included in the "total income" calculation? The Government of Canada site does not seem to be very clear. Thanks.
Q: What are the best opportunities you see to play the emerging hydrogen theme? I have starter positions in Ballard and Xebec, not sure if I'm missing anything obvious or should add to those?
Q: I am wondering about what stocks in the US you would see as cratering upon the announcement of an effective vaccine for covid. I see a significant vaccine breakthrough happening sometime within the next 6 months (or sooner) albeit with its attendant issues such as who gets it first, distribution, quantities, cost, etc but at least step 1 would be having the vaccine. I mean, just consider the gigantic effort being put into vaccine development. In particular, I'm wondering about buying ZOOM which now has a P/E in the 600 to 700(!) plus range depending on where you look. CNBC lists Zoom's peers among others as TEAM and DOCU which I already have full positions in. These all look wonderful to me now in a heavily covid world, but are they set up for a huge decline upon a significant vaccine announcement? Thank you.
Q: Given your answer a month ago
"We would prefer WFT today. HDI is small, but is expected to show good earnings growth. The balance sheet is a bit stretched but with good cash flow growth this becomes less of a problem. The stock is acting well and there has been some insider buying. It is very cheap on valuation if its growth expectations come through. It is not likely too late."
Has anything changed, Looking into the future do you see this sector as a hold or should I take my profit.
Q: Every year I look for a beaten down company - out of favor this year but with an intact business likely to do well in future years. What should we be keeping our eyes on?